Description

Ecosprin 75 (Aspirin) for Clot Prevention: Clinical Guide

Ecosprin 75 is a gastro-resistant tablet contains 75 mg of aspirin.

Aspirin is a salicylate non-steroidal anti-inflammatory drug (NSAID). At 75mg, clinicians use its antiplatelet action rather than its pain-relieving effects.

Danamep 75mg contains the same active ingredient. However, Danamep is dispersible, while Ecosprin 75mg tablets are gastro-resistant (coated to pass through the stomach before dissolving).

Feature	Ecosprin 75	Danamep
Active ingredient	Aspirin	Aspirin
Strength	75 mg	75 mg
Formulation	Gastro-resistant	Dispersible
Mechanism	Irreversible platelet COX inhibition	Irreversible platelet COX inhibition
Chemical class	Salicylate NSAID	Salicylate NSAID
Therapeutic effect	Reduces platelet aggregation	Reduces platelet aggregation

Available Strengths

• Ecosprin 75
• Ecosprin AV 75
• Ecosprin 325
• Ecosprin AV 75/40
• Ecosprin 150
• Ecosprin AV 150
• Ecosprin Gold 10
• Ecosprin Gold 10 Forte
• Ecosprin Gold 40
• Ecosprin AV 150 / 20

Mechanism of Action

Aspirin inhibits cyclooxygenase-1 (COX-1, an enzyme involved in blood clotting). This stops thromboxane A2 (a chemical causing platelets to stick together).

Platelets cannot replace inhibited COX-1. The antiplatelet effect therefore persists throughout their seven- to ten-day lifespan.

Clinical Uses

• Secondary prevention after myocardial infarction (a heart attack caused by blocked blood flow) or ischaemic stroke (a stroke caused by a blood clot).
• Prevention following a transient ischaemic attack (a mini-stroke caused by a temporary brain blood clot) or vascular surgery.
• Other cardiovascular indications identified by a clinician.

Aspirin 75 mg is unsuitable for rapid relief of pain or fever. Swallow gastro-resistant tablets whole unless the leaflet states otherwise.

Safety Information

Category	Details
Common Effects	Indigestion and easier bleeding or bruising
Serious Effects	Gastrointestinal bleeding, ulceration, bronchospasm (sudden airway tightening), and severe hypersensitivity (allergic reaction)

Avoid treatment with active ulcers, bleeding disorders or severe liver or kidney disease. Avoid it after aspirin-triggered asthma.

Interactions include warfarin, other antiplatelets, NSAIDs, corticosteroids, SSRIs and methotrexate. These combinations may increase bleeding or toxicity.

Overdose can cause tinnitus (ringing in the ears), vomiting, sweating, rapid breathing and confusion. Seek emergency help after any suspected overdose.

Report suspected reactions through the MHRA Yellow Card Scheme. Always consult a qualified UK healthcare professional before starting or changing treatment.

Safety Advice

Liver

Tell your clinician about liver impairment. Severe impairment is a contraindication.

Kidney

Use with caution in cases of reduced kidney function or dehydration. Severe impairment is a contraindication.

Alcohol

Alcohol may increase stomach irritation and bleeding risk. Ask your clinician about safe intake.

Driving

Treatment does not usually affect driving. Do not drive if you feel unwell.

Pregnancy

Use low-dose treatment only under obstetric supervision. Guidance depends on dose, trimester and indication.

Breastfeeding

Ask a clinician before use. Product guidance and treatment duration affect suitability.

Accessing Treatment Responsibly

Access Ecosprin aspirin 75 mg gastro-resistant tablets only through regulated pharmacy supply. Confirm authorisation and supply requirements first.

Do not replace prescribed 75 mg aspirin tablets independently. A UK pharmacist or prescriber must approve any formulation change.

FAQ

Q: Can I obtain 75mg aspirin over the counter?

A: Yes. Some 75mg aspirin medicines are available over the counter from UK pharmacies with pharmacist advice. Speak to a doctor before starting low-dose aspirin because it can cause bleeding

Conclusion

Ecosprin 75 contains 75 mg of aspirin, which has an antiplatelet effect that helps prevent blood clots. Patients are required to undergo a thorough clinical review before any changes to their current medicines are considered.

References & Official Data Sources

• NICE: https://www.nice.org.uk/guidance/ng238/resources/patient-decision-aid-pdf-243780159
• NHS: https://www.nhs.uk/medicines/aspirin/
• MHRA Yellow Card Scheme: https://yellowcard.mhra.gov.uk/

Medical Disclaimer

This guide does not replace diagnosis, prescribing advice or the patient information leaflet.